Tune in to WBZ | CBS Boston for an insightful look into how MiNK is advancing novel allogeneic iNKT cell therapies for patients with solid tumor cancers.
Photo: minkherapeutics.com
Spotlight on MiNK: Advancing Allogeneic iNKT Cell Therapies for Solid Tumor Cancers
Medically reviewed Jun 2, 2023 by Mariam Khachatryan, MD